Cardlytics Inc logo

CDLX - Cardlytics Inc Share Price

$110.9 -1.0  -0.9%

Last Trade - 09/04/21

Consumer Cyclicals
Large Cap
Market Cap £2.57bn
Enterprise Value £2.48bn
Revenue £136.3m
Position in Universe 1710th / 6827
Unlock CDLX Revenue
Relative Strength (%)
1m -16.3%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -31.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
77.6 112.8 130.4 150.7 210.4 186.9 267.9 370 +19.2%
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020,Cardlytics Inc revenues decreased 11% to $186.9M. Net lossincreased from $17.1M to $55.4M. Revenues reflect UnitedStates segment decrease of 8% to $172.8M, United Kingdomsegment decrease of 40% to $14.1M. Higher net loss reflectsStock-based Compensation in increase of 79% to $16.6M(expense), Stock-based Compensation in SGA increase from$4.2M to $9.9M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


CDLX Revenue Unlock CDLX Revenue

Net Income

CDLX Net Income Unlock CDLX Revenue

Normalised EPS

CDLX Normalised EPS Unlock CDLX Revenue

PE Ratio Range

CDLX PE Ratio Range Unlock CDLX Revenue

Dividend Yield Range

CDLX Dividend Yield Range Unlock CDLX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
CDLX EPS Forecasts Unlock CDLX Revenue
Profile Summary

Cardlytics, Inc. is engaged in developing a purchase intelligence platform. The Company delivers relevant and measurable marketing analysis with purchase data from over financial institutions. The purchase data includes debit, credit, and bill pay data from online and in-store transactions. It helps the marketers identify, reach and influence likely buyers at scale, and measure the impact of marketing spends. The Company also operates an advertising channel, Cardlytics Direct. Cardlytics Direct delivers tailored marketing for marketers and financial institutions (FI). It provides personalized offers and suggestions for FI consumers on their purchase. It also provides transaction-based advertising platform that helps consumers to earn cash back when they shop, dine or book hotels.

Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated June 26, 2008
Public Since February 9, 2018
No. of Shareholders: 45
No. of Employees: 471
Sector Consumer Cyclicals
Industry Media & Publishing
Index Nasdaq Composite ,
Exchange NASDAQ Global Market
Shares in Issue 31,769,783
Free Float (0.0%)
Eligible for
CDLX Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for CDLX
Upcoming Events for CDLX
Monday 10th May, 2021 Estimate
Q1 2021 Cardlytics Inc Earnings Release
Friday 21st May, 2021
Cardlytics Inc Annual Shareholders Meeting
Wednesday 2nd June, 2021 Estimate
Cardlytics Inc Annual Shareholders Meeting
Monday 2nd August, 2021 Estimate
Q2 2021 Cardlytics Inc Earnings Release
Frequently Asked Questions for Cardlytics Inc
What is the Cardlytics Inc share price?

As of 09/04/21, shares in Cardlytics Inc are trading at $110.9, giving the company a market capitalisation of £2.57bn. This share price information is delayed by 15 minutes.

How has the Cardlytics Inc share price performed this year?

Shares in Cardlytics Inc are currently trading at $110.9 and the price has moved by 0.154k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Cardlytics Inc price has moved by 71.13% over the past year.

What are the analyst and broker recommendations for Cardlytics Inc?

Of the analysts with advisory recommendations for Cardlytics Inc, there are there are currently 0 "buy" , 6 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Cardlytics Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Cardlytics Inc next release its financial results?

Cardlytics Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Cardlytics Inc dividend yield?

Cardlytics Inc does not currently pay a dividend.

Does Cardlytics Inc pay a dividend?

Cardlytics Inc does not currently pay a dividend.

When does Cardlytics Inc next pay dividends?

Cardlytics Inc does not currently pay a dividend.

How do I buy Cardlytics Inc shares?

To buy shares in Cardlytics Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Cardlytics Inc?

Shares in Cardlytics Inc are currently trading at $110.9, giving the company a market capitalisation of £2.57bn.

Where are Cardlytics Inc shares listed? Where are Cardlytics Inc shares listed?

Here are the trading details for Cardlytics Inc:

Country of listing: United States
Exchange: NMQ
Ticker Symbol: CDLX
What kind of share is Cardlytics Inc?

Based on an overall assessment of its quality, value and momentum, Cardlytics Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Cardlytics Inc share price forecast 2021?

Shares in Cardlytics Inc are currently priced at $110.9. At that level they are trading at 29.17% discount to the analyst consensus target price of 0.00.

Analysts covering Cardlytics Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.618 for the next financial year.

How can I tell whether the Cardlytics Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cardlytics Inc. Over the past six months, the relative strength of its shares against the market has been 18.22%. At the current price of $110.9, shares in Cardlytics Inc are trading at 7.86% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Cardlytics Inc PE Ratio?

We were not able to find PE ratio data for Cardlytics Inc.

Who are the key directors of Cardlytics Inc?

Cardlytics Inc's management team is headed by:

Scott Grimes - CHM
Lynne Laube - CEO
Kirk Somers - CHO
David Adams - IND
John Balen - LED
Mark Johnson - IND
John Klinck - IND
Andrew Christiansen - CFO
Jessica Jensen - DRC
Who are the major shareholders of Cardlytics Inc?

Here are the top five shareholders of Cardlytics Inc based on the size of their shareholding:

CAS Investment Partners, LLC Hedge Fund
Percentage owned: 14.13% (4.49m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 5.78% (1.84m shares)
Wellington Management Company, LLP Investment Advisor/Hedge Fund
Percentage owned: 5.58% (1.77m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 5.48% (1.74m shares)
Aimia Inc Corporation
Percentage owned: 3.46% (1.10m shares)
Similar to CDLX
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.